$1 Billion is the total value of venBio Partners LLC's 9 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 10.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | $716,436,000 | +35.1% | 9,699,925 | 0.0% | 71.38% | +14.0% | |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $117,412,000 | +18.7% | 3,063,194 | -12.6% | 11.70% | +0.2% |
| AKRO | AKERO THERAPEUTICS INC | $49,187,000 | -9.9% | 2,200,778 | 0.0% | 4.90% | -24.0% | |
| PHVS | PHARVARIS N V | $40,838,000 | -4.8% | 2,303,310 | 0.0% | 4.07% | -19.7% | |
| IMPL | IMPEL NEUROPHARMA INC | $33,614,000 | +37.6% | 2,759,791 | 0.0% | 3.35% | +16.2% | |
| ELEV | ELEVATION ONCOLOGY INC | $20,318,000 | -42.6% | 2,608,167 | 0.0% | 2.02% | -51.5% | |
| CMPI | CHECKMATE PHARMACEUTICALS IN | $14,583,000 | -33.4% | 3,673,374 | 0.0% | 1.45% | -43.8% | |
| MTCR | METACRINE INC | $10,493,000 | -9.7% | 3,059,123 | 0.0% | 1.04% | -23.8% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $887,000 | -16.2% | 161,897 | 0.0% | 0.09% | -29.6% | |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -411,471 | -100.0% | -3.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERONA PHARMA PLC | 15 | Q2 2022 | 22.2% |
| AKERO THERAPEUTICS INC | 14 | Q3 2022 | 65.3% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 73.8% |
| HARMONY BIOSCIENCES HLDGS IN | 13 | Q3 2023 | 21.1% |
| APELLIS PHARMACEUTICALS INC | 11 | Q2 2021 | 62.0% |
| PHARVARIS N V | 11 | Q3 2023 | 25.2% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.3% |
| ELEVATION ONCOLOGY INC | 10 | Q3 2023 | 4.2% |
| VENTYX BIOSCIENCES INC | 8 | Q3 2023 | 42.7% |
| PRECISION BIOSCIENCES INC | 7 | Q3 2020 | 62.0% |
View venBio Partners LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View venBio Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.